Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration

Author(s):  Trissel Lawrence A, Gilbert Doward L, Wolkin Allan C

Issue:  May/Jun 1999 - Compounding for Animals
View All Articles in Issue

Page(s):  241-244

Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration Page 1
Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration Page 2
Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration Page 3
Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration Page 4

Download in electronic PDF format for $75

Abstract:  The compatibility of docetaxel with 81 secondary additives during simulated Y-site injection was evaluated by visual observation with the unaided eye and a Tyndall beam as well as with electronic turbidity measurement.

Five milliliters of docetaxel 0.9 mg/mL in 5% dextrose injection was combined with 5 mL of solutions of 81 secondary additives including supportive-care drugs and anti-infectives in 5% dextrose injection or, if necessary to avoid incompatibilities with the diluent, 0.9% sodium chloride injection. Visual examinations were performed in fluorescent light with the unaided eye and a Tyndall beam (high-intensity monodirectional light beam) to enhance visualization of small particles and low-level turbidity. The turbidity of each sample was quantitated as well. Evaluation of the samples was performed initially and at one and four hours after preparation.

Most of the drugs tested were physically compatible with docetaxel at 0.9 mg/mL. However, three drugs exhibited incompatibilities with docetaxel within the four-hour observation period. Amphotericin B resulted in the formation of a substantially more intense haze measuring about 11.5 nephelometric turbidity units (NTU) after four hours; the haze was visible in normal room light. The nalbuphine hydrochloride mixtures resulted in a small increase of about 0.8 NTU in subvisual haze. The methylprednisolone sodium succinate combination resulted in a small loss of the expected natural haze of about 0.5 to 0.6 NTU.

Docetaxel was physically compatible with 78 supportive care and anti-infective drugs during simulated simultaneous Y-site administration. However, amphotericin B, nalbuphine hydrochloride, and methylprednisolone sodium succinate resulted in physical incompatibilities. Simultaneous Y-site administration of these three drugs with docetaxel should be avoided.

Related Keywords: nalbuphine hydrochloride, methylprednisolone sodium succinate

Related Categories: CANCER AND AIDS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration
Trissel Lawrence A
, Gilbert Doward L, Wolkin Allan C
May/Jun 1999
Pg. 241-244

Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs
Trissel Lawrence A
, Saenz Christopher
Jul/Aug 2002
Pg. 311-315

Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Lu Juan
, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jan/Feb 2021
Pg. 52-61

Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Kupiec Thomas C
, Ben Michel, Trusley Craig, Trissel Lawrence A
Mar/Apr 2008
Pg. 170-173

Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Ben Michel
, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Nov/Dec 2007
Pg. 520-524

Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Trusley Craig
, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008
Pg. 156-160

Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs
Trissel Lawrence A
, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S, Retzinger Julie P
May/Jun 2002
Pg. 230-233

Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs
Trissel Lawrence A
, Williams Kimberly Y, Baker Ma
Jan/Feb 2001
Pg. 69-73

Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration
Zhang Yang
, Scarlett Cameron, Hutson Paul
Jan/Feb 2012
Pg. 82-85

Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration
Trissel Lawrence A
, Trusley Craig, Kupiec Thomas C, Ben Michel
Jan/Feb 2009
Pg. 78-80

Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration
Chan Pak
, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2008
Pg. 276-278

Compatibility of Amiodarone Hydrochloride with Vasopressin During Simulated Y-site Administration
Ramaley Corrine C
, Li Feng, Du Chengan
Sep/Oct 2013
Pg. 436-438

Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration
Trissel Lawrence A
, Xu Quanyun A, Zhang Yanping
May/Jun 2006
Pg. 234-236

Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration
Trusley Craig
, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2006
Pg. 230-233

Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration
Inagaki Kazuhiro
, Kambara Motoya, Mizuno Munemichi, Gill Mark A, Nishida Mikio
Jul/Aug 1998
Pg. 318-321

Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration
Ben Michel
, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Jul/Aug 2008
Pg. 368-371

Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration
Mody Vicky
, Shah Samit, Patel Jaymin, Thomas Michael C
May/Jun 2016
Pg. 236-238

Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration
Inagaki Kazuhiro
, Miyamoto Yuriko, Kurata Niroko, Nakane Shigeki, Gill Mark A, Nishida Mikio
Mar/Apr 2000
Pg. 150-153

Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration
Trissel Lawrence A
, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S
Jul/Aug 2001
Pg. 314-319

Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration
Trusley Craig
, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Jan/Feb 2007
Pg. 82-85

Return to Top